Evidence map›Paper›PMID 36535754›Full record

ArticleJournal of medical genetics2023

Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events.

Alba Segarra-Casas, Cristina Domínguez-González, Aurelio Hernández-Laín, Maria Teresa Sanchez-Calvin, Ana Camacho, Eloy Rivas, Andrea Campo-Barasoain, Marcos Madruga, Carlos Ortez, Daniel Natera-de Benito and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

Alba Segarra-CasasGenetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0001-5185-5031
Cristina Domínguez-GonzálezNeuromuscular Unit, Neurology Department, imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID 0000-0001-5151-988X
Aurelio Hernández-LaínNeuropathology Unit, imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.
Maria Teresa Sanchez-CalvinClinical Genetics Unit, Genetics department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ana CamachoPaediatric Neurology Unit, Universidad Complutense de Madrid, Hospital Universitario 12 de Octubre, Madrid, Spain.
Eloy RivasPathology Department, Instituto de Biomedicina de Sevilla, CSIC, Universidad de Sevilla, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
Andrea Campo-BarasoainUGC Pediatrics Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Marcos MadrugaNeurology Department, Neurolinkia, Sevilla, Spain.
Carlos OrtezNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Daniel Natera-de BenitoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Andrés NascimentoCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Anna CodinaApplied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Maria Jose RodriguezGenetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Pia GallanoGenetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain pgallano@santpau.cat.
Lidia Gonzalez-QueredaGenetics Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Hospital Sant Joan de Déu Barcelona · ESInstituto de Salud Carlos III · ESHospital Universitario 12 De Octubre · ESHospital de Sant Pau · ESHospital San Juan de la Cruz · ESHospital Universitario Virgen Macarena · ESInstituto de Biomedicina de Sevilla · ESRed de Investigación en Actividades Preventivas y Promoción de la Salud · ESUniversidad Complutense de Madrid · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to 7% of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) remain genetically undiagnosed after routine genetic testing. These patients are thought to carry deep intronic variants, structural variants or splicing alterations not detected through multiplex ligation-dependent probe amplification or exome sequencing.

methodsRNA was extracted from seven muscle biopsy samples of patients with genetically undiagnosed DMD/BMD after routine genetic diagnosis. RT-PCR of the

resultsWe identified an alteration in the mRNA level in all the patients. We detected three pseudoexons in

conclusionThese findings indicate that mRNA analysis of the

Indexed as

Muscular Dystrophy, DuchenneDystrophinHumansMultiplex Polymerase Chain ReactionMutationRNA, MessengerDystrophinRNA, MessengerCardiomyopathiesDiagnosisFrameshift MutationNeuromuscular DiseasesSequence Analysis, RNA

Identifiers

PMID36535754
PMCPMC10313949
OpenAlexW4311943296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.